+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Interventional Pulmonology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5724535

Industry Outlook

The interventional pulmonology market is set to grow at a compounded annual growth rate (CAGR) of 4.8% during the forecast period from 2022 to 2030. As per the statistics provided by World Health Organization (WHO), in 2019 approximately 2.09 million people died due to lung cancer. Tobacco smoking is the leading causes of formation of malignant tumours and neoplasms in the lungs. Interventional pulmonology is a relatively new field which has gained tremendous attraction in the last decade which employs sophisticated tools to perform diagnosis and treatment of various pulmonary disorders. Apart from pulmonologist cardiothoracic surgeons also routinely perform interventional pulmonology procedures.

Accurate diagnosis, precise sample collection and increasing number of lung complications drive the flexible bronchoscopy market growth

Flexible bronchoscopy is dominating the procedure type segment for interventional pulmonology market. Flexible bronchoscopy is useful in diagnosing different stages of lung cancer, palliative care by debulking endobronchial lesions and treating in airway stenosis. Its inherent features such as accurate diagnosis, precise sample collection and significant rise in lung complication together drive the flexible bronchoscopy market growth. Pleuroscopy is gaining huge demand as an alternative to video assisted thoracoscopic surgery (VATS) which is employed for the diagnosis of pleural effusion of unknown etiology. It is a minimally invasive surgical procedure and has successfully achieved 100% accurate diagnosis of tuberculous effusion. It is relatively well tolerated procedure with negligible complications.

Rising prevalence of lung cancer and growing health awareness together drive the market growth in North America

In the current scenario North America is dominating the regional segment for interventional pulmonology market. The factors responsible for its market share of 35% are rising prevalence of lung cancer and growing health awareness. According to American Lung Association (ALA) in 2019, 234,030 new cases of lung cancer were diagnosed in the United States which represents 13% of all diagnosed cancer. Europe holds 30% market share owing to the significant rise in air pollution and tobacco smoking. Stringent norms related to early diagnosis and medical intervention drive the interventional pulmonology market growth in European region. Asia Pacific is representing 15% market share on account of increasing establishment of subsidiaries and retail outlets of major players such as Boston Scientific Corporation, Karl Storz, Medtronic, Plc., and Terumo Corporation etc. Supportive regulatory environment provided by regional healthcare bodies further bolster the market growth in Asia Pacific region.

Medical device companies competing in interventional pulmonology market are Boston Scientific Corporation, BTG, Plc., Ethicon, Inc., ENDO-FLEX GmbH, HealthTronics, Inc., Karl Storz, Medtronic, Plc., Pulmonx, Inc., Terumo Corporation and Varian Medical Systems, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Interventional Pulmonology market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Interventional Pulmonology market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Procedure

  • Flexible Bronchoscopy
  • Rigid Bronchoscopy
  • Bronchoalveolar Lavage
  • Lung Biopsy
  • Bronchial Stent
  • Balloon Bronchoplasty
  • Pleuroscopy
  • Others

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Interventional Pulmonology market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Interventional Pulmonology market?
  • Which is the largest regional market for Interventional Pulmonology market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Interventional Pulmonology market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Interventional Pulmonology market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Interventional Pulmonology Market
2.2. Global Interventional Pulmonology Market, By Procedure, 2021 (US$ Million)
2.3. Global Interventional Pulmonology Market, By Geography, 2021 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2021

3. Interventional Pulmonology Market: Competitive Analysis
3.1. Market Positioning of Key Interventional Pulmonology Market Vendors
3.2. Strategies Adopted by Interventional Pulmonology Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030

4. Interventional Pulmonology Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Interventional Pulmonology Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Flexible Bronchoscopy
5.3.2. Rigid Bronchoscopy
5.3.3. Bronchoalveolar Lavage
5.3.4. Lung Biopsy
5.3.5. Bronchial Stent
5.3.6. Balloon Bronchoplasty
5.3.7. Pleuroscopy
5.3.8. Others

6. North America Interventional Pulmonology Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
6.3.Interventional Pulmonology Market: By Region, 2020-2030, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)

7. UK and European Union Interventional Pulmonology Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
7.3.Interventional Pulmonology Market: By Region, 2020-2030, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
7.3.1.5. France
7.3.1.5.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)

8. Asia Pacific Interventional Pulmonology Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
8.3.Interventional Pulmonology Market: By Region, 2020-2030, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
8.3.1.3. India
8.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)

9. Latin America Interventional Pulmonology Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
9.3.Interventional Pulmonology Market: By Region, 2020-2030, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)

10. Middle East and Africa Interventional Pulmonology Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
10.3.Interventional Pulmonology Market: By Region, 2020-2030, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Interventional Pulmonology Market: By Procedure, 2020-2030, USD (Million)

11. Company Profile
11.1. Boston Scientific Corporation
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. BTG, plc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Ethicon, Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. ENDO-FLEX GmbH.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. HealthTronics, Inc.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Karl Storz
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Medtronic, plc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Pulmonx, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Terumo Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Varian Medical Systems, Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives

List of Figures
Figure 1 Global Interventional Pulmonology Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Interventional Pulmonology Market: Quality Assurance
Figure 5 Global Interventional Pulmonology Market, By Procedure, 2021
Figure 6 Global Interventional Pulmonology Market, By Geography, 2021
Figure 7 Market Geographical Opportunity Matrix - Global Interventional Pulmonology Market, 2021
Figure 8 Market Positioning of Key Interventional Pulmonology Market Players, 2021
Figure 9 Global Interventional Pulmonology Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 10 Global Interventional Pulmonology Market, By Procedure, 2021 Vs 2030, %
Figure 11 U.S. Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 12 Canada Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 13 Rest of North America Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 14 UK Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 15 Germany Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 16 Spain Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 17 Italy Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 18 France Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 19 Rest of Europe Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 20 China Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 21 Japan Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 22 India Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 23 Australia Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 24 South Korea Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 25 Rest of Asia Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 26 Brazil Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 27 Mexico Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 28 Rest of Latin America Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 29 GCC Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 30 Africa Interventional Pulmonology Market (US$ Million), 2020 - 2030
Figure 31 Rest of Middle East and Africa Interventional Pulmonology Market (US$ Million), 2020 - 2030

List of Tables
Table 1 Global Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 2 North America Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 3 U.S. Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 4 Canada Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 5 Rest of North America Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 6 UK and European Union Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 7 UK Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 8 Germany Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 9 Spain Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 10 Italy Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 11 France Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 12 Rest of Europe Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 13 Asia Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 14 China Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 15 Japan Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 16 India Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 17 Australia Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 18 South Korea Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 19 Latin America Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 20 Brazil Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 21 Mexico Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 22 Rest of Latin America Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 23 Middle East and Africa Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 24 GCC Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 25 Africa Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)
Table 26 Rest of Middle East and Africa Interventional Pulmonology Market By Procedure, 2020-2030, USD (Million)

Companies Mentioned

  • Boston Scientific Corporation
  • BTG Plc.
  • Ethicon Inc.
  • ENDO-FLEX GmbH
  • HealthTronics Inc.
  • Karl Storz
  • Medtronic Plc.
  • Pulmonx Inc.
  • Terumo Corporation
  • Varian Medical Systems Inc.